Skip to main content

Table 1 Available studies (NCT = ClinicalTrials.gov registry number)

From: Meta-analysis of efficacy and safety of intravenous ferric carboxymaltose (Ferinject) from clinical trial reports and published trial data

CTR    Condition    NCT    Published study
1VIT04004 [44]    Chronic kidney disease      Qunibi et al. Nephrol Dial Transplant 2010 doi: 10.1093/ndt/gfq613 [45]
1VIT04005 [47]    Chronic kidney disease      No publication identified
VIT-IV-CL-015 [46]    Haemodialysis      No publication identified
53214 [48]    Haemodialysis      Covic & Mircescu. Nephrol Dial Transplant 2010 25: 2722-2730 [49]
VIT-IV-CL-009 [50]    Post partum anaemia      Breymann et al. Int J Gynecol Obstet 2008 101: 67-73 [51]
1VIT06011 [52]    Post partum anaemia      Seid et al. Am J Obstet Gynecol 2008 199:435.e1-7 [53]
1VIT04002/4003 [54]    Uterine bleeding    NCT00395993    Van Wyck et al. Transfusion 2009 49: 2719-2728 [41]
No CTR available    Post partum anaemia    NCT00396292    Van Wyck et al. Obst & Gynecol 2007 110:267-278 [55]
VIT-IV-CL-03 [56]    GI causes of anaemia      No publication identified
VIT-IV-CL-008 [57]    Inflammatory bowel disease      Kulnigg et al. Am J Gastroeneterol 2008 24:1507-1523 [58]
1VIT05006 [59]    Iron deficiency anaemia      Bailie et al. Hemodialysis International 2010 14: 47-54 [35]
CARS 1 [60]    Iron deficiency anaemia      No publication identified
No CTR available    Congestive heart failure    NCT00520780    Anker et al. NEJM 2009 361 [42]
No CTR available    CKD design    NCT00981045    Szczech et al. Nephrol Dial Transplant 2010 25: 2368-2375 [61]